The Interkingdom Interaction with Staphylococcus Influences the Antifungal Susceptibility of the Cutaneous Fungus Malassezia
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The skin is a dynamic ecosystem on which diverse microbes reside. The interkingdom interaction between microbial species in the skin microbiota is thought to influence the health and disease of the skin although the roles of the intra- and interkingdom interactions remain to be elucidated. In this context, the interactions between Malassezia and Staphylococcus, the most dominant microorganisms in the skin microbiota, have gained attention. This study investigated how the interaction between Malassezia and Staphylococcus affected the antifungal susceptibility of the fungus to the azole antifungal drug ketoconazole. The susceptibility was significantly decreased when Malassezia was co-cultured with Staphylococcus. We found that acidification of the environment by organic acids produced by Staphylococcus influenced the decrease of the ketoconazole susceptibility of M. restricta in the co-culturing condition. Furthermore, our data demonstrated that the significant increased ergosterol content and cell membrane and wall thickness of the M. restricta cells grown in the acidic environment may be the main cause of the altered azole susceptibility of the fungus. Overall, our study suggests that the interaction between Malassezia and Staphylococcus influences the antifungal susceptibility of the fungus and that pH has a critical role in the polymicrobial interaction in the skin environment.
Abstract
The skin is a dynamic ecosystem on which diverse microbes reside. The interkingdom interaction between microbial species in the skin microbiota is thought to influence the health and disease of the skin although the roles of the intra- and interkingdom interactions remain to be elucidated. In this context, the interactions between Malassezia and Staphylococcus, the most dominant microorganisms in the skin microbiota, have gained attention. This study investigated how the interaction between Malassezia and Staphylococcus affected the antifungal susceptibility of the fungus to the azole antifungal drug ketoconazole. The susceptibility was significantly decreased when Malassezia was co-cultured with Staphylococcus. We found that acidification of the environment by organic acids produced by Staphylococcus influenced the decrease of the ketoconazole susceptibility of M. restricta in the co-culturing condition. Furthermore, our data demonstrated that the significant increased ergosterol content and cell membrane and wall thickness of the M. restricta cells grown in the acidic environment may be the main cause of the altered azole susceptibility of the fungus. Overall, our study suggests that the interaction between Malassezia and Staphylococcus influences the antifungal susceptibility of the fungus and that pH has a critical role in the polymicrobial interaction in the skin environment.
참고문헌 (55)
- Ramsey MM, "Staphylococcus aureus shifts toward commensalism in response to Corynebacterium species", Front. Microbiol, 7, pp.1230~ (2016)
- Kim HJ, "Aged related human skin microbiome and mycobiome in Korean women", Sci. Rep, 12, pp.2351~ (2022)
- Tao R, "Dysbiosis of skin mycobiome in atopic dermatitis", Mycoses, 65, pp.285~293 (2022)
- Chatterjee P, "Review of potential Pseudomonas weaponry, relevant to the Pseudomonas-Aspergillus interplay, for the mycology community", J. Fungi (Basel), 6, pp.81~ (2020)
- Al-Fattani MA, "Penetration of Candida biofilms by antifungal agents", Antimicrob. Agents Chemother, 48, pp.3291~3297 (2004)
- Li H, "Skin commensal Malassezia globosa secreted protease attenuates Staphylococcus aureus biofilm formation", J. Invest. Dermatol, 138, pp.1137~1145 (2018)
- Guého E, "The genus Malassezia with description of four new species", Antonie Van Leeuwenhoek, 69, pp.337~355 (1996)
- Cho YJ, "Genome of Malassezia arunalokei and its distribution on facial skin", Microbiol. Spectr, 10, pp.e0050622~ (2022)
- Honnavar P, "Malassezia arunalokei sp. nov., a novel yeast species isolated from seborrheic dermatitis patients and healthy individuals from India", J. Clin. Microbiol, 54, pp.1826~1834 (2016)
- Theelen B, "Malassezia ecology, pathophysiology, and treatment", Med. Mycol, 56, pp.S10~S25 (2018)
- Gupta AK, "Skin diseases associated with Malassezia species", J. Am. Acad. Dermatol, 51, pp.785~798 (2004)
- Piérard-Franchimont C, "Effect of ketoconazole 1% and 2% shampoos on severe dandruff and seborrhoeic dermatitis: clinical, squamometric and mycological assessments", Dermatology, 202, pp.171~176 (2001)
- Goularte-Silva V, "Ketoconazole beyond antifungal activity: Bioinformatics-based hypothesis on lipid metabolism in dandruff and seborrheic dermatitis", Exp. Dermatol, 31, pp.821~822 (2022)
- Levine HB, "Oral therapy for experimental coccidioidomycosis with R41 400 (ketoconazole), a new imidazole", Am. Rev. Respir. Dis, 118, pp.715~721 (1978)
- Prasad R, "Antifungals: Mechanism of action and drug resistance", Adv. Exp. Med. Biol, 892, pp.327~349 (2016)
- Kelly SL, "Mode of action and resistance to azole antifungals associated with the formation of 14α-methylergosta-8, 24 (28)-dien-3β, 6α-diol", Biochem. Biophys. Res. Commun, 207, pp.910~915 (1995)
- Park M, "Genomic multiplication and drug efflux influence ketoconazole resistance in Malassezia restricta", Front. Cell Infect. Microbiol, 10, pp.191~ (2020)
- 김민철, "Genomic Tandem Quadruplication is Associated with Ketoconazole Resistance in Malassezia pachydermatis", Journal of Microbiology and Biotechnology, 28(11), pp.1937~1945 (2018), 한국미생물·생명공학회
- Sanguinetti M, "Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance", Antimicrob. Agents Chemother, 49, pp.668~679 (2005)
- Cowen LE, "Mechanisms of antifungal drug resistance", Cold Spring Harb. Perspect. Med, 5, pp.a019752~ (2015)
- Geber A, "Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility", Antimicrob. Agents and Chemother, 39, pp.2708~2717 (1995)
- Eddouzi J, "Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals", Antimicrob. Agents Chemother, 57, pp.3182~3193 (2013)
- Park M, "Whole genome sequencing analysis of the cutaneous pathogenic yeast Malassezia restricta and identification of the major lipase expressed on the scalp of patients with dandruff", Mycoses, 60, pp.188~197 (2017)
- Leeming JP, "Improved methods for isolation and enumeration of Malassezia furfur from human skin", J. Clin. Microbiol, 25, pp.2017~2019 (1987)
- Midgley G, "The diversity of Pityrosporum (Malassezia) yeasts in vivo and in vitro", Mycopathologia, 106, pp.143~153 (1989)
- Doyle JE, "Limitations of thioglycolate broth as a sterility test medium for materials exposed to gaseous ethylene oxide", Appl. Microbiol, 16, pp.1742~1744 (1968)
- Piddock LJ, "Techniques used for the determination of antimicrobial resistance and sensitivity in bacteria. Antimicrobial Agents Research Group", J. Appl. Bacteriol, 68, pp.307~318 (1990)
- Kim HJ, "Short-term adaptation modulates anaerobic metabolic flux to succinate by activating ExuT, a novel Dglucose transporter in Escherichia coli", Front. Microbiol, 11, pp.27~ (2020)
- Varga M, "Determination of ergosterol in Fusarium-infected wheat by liquid chromatographyatmospheric pressure photoionization mass spectrometry", J. Chromatogr. A, 1103, pp.278~283 (2006)
- Park M, "A novel virus alters gene expression and vacuolar morphology in Malassezia cells and induces a TLR3-mediated inflammatory immune response", mBio, 11, pp.e01521-20~ (2020)
- Findley K, "Topographic diversity of fungal and bacterial communities in human skin", Nature, 498, pp.367~370 (2013)
- Danby CS, "Effect of pH on in vitro susceptibility of Candida glabrata and Candida albicans to 11 antifungal agents and implications for clinical use", Antimicrob. Agents Chemother, 56, pp.1403~1406 (2012)
- Liu-Walsh F, "Prebiotic colloidal oat supports the growth of cutaneous commensal bacteria including S. epidermidis and enhances the production of lactic acid", Clin. Cosmet. Investig. Dermatol, 14, pp.73~82 (2021)
- vanden Bossche H, "Characterization of an azole-resistant Candida glabrata isolate", Antimicrob. Agents Chemother, 36, pp.2602~2610 (1992)
- Khalaf RA, "Whole genome sequencing of a clinical drug resistant Candida albicans isolate reveals known and novel mutations in genes involved in resistance acquisition mechanisms", J. Med. Microbiol, 70, pp.001351~ (2021)
- Jiang C, "Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China", J. Antimicrob. Chemother, 68, pp.778~785 (2013)
- Prasad T, "Unexpected link between iron and drug resistance of Candida spp.: Iron depletion enhances membrane fluidity and drug diffusion, leading to drug-susceptible cells", Antimicrob. Agents Chemother, 50, pp.3597~3606 (2006)
- Zarember KA, "Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus", Antimicrob. Agents Chemother, 53, pp.2654~2656 (2009)
- Kim J, "A defect in iron uptake enhances the susceptibility of Cryptococcus neoformans to azole antifungal drugs", Fungal Genet. Biol, 49, pp.955~966 (2012)
- Hosogaya N, "The heme-binding protein Dap1 links iron homeostasis to azole resistance via the P450 protein Erg11 in Candida glabrata", FEMS Yeast Res, 13, pp.411~421 (2013)
- Craven RJ, "Regulation of iron homeostasis mediated by the heme-binding protein Dap1 (damage resistance protein 1) via the P450 protein Erg11", Cyp51, 2007, pp.282, 36543~36551
- Agarwal AK, "Role of heme in the antifungal activity of the azaoxoaporphine alkaloid sampangine", Eukaryot Cell, 7, pp.387~400 (2008)
- Rogers TE, "Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo", Antimicrob. Agents Chemother, 30, pp.418~422 (1986)
- McIntyre KA, "In vitro susceptibilities of yeasts to a new antifungal triazole, SCH 39304: effects of test conditions and relation to in vivo efficacy", Antimicrob. Agents Chemother, 33, pp.1095~1100 (1989)
- Peng T, "In vitro studies of a new antifungal triazole, D0870, against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts", Antimicrob. Agents Chemother, 37, pp.2126~2131 (1993)
- Liu W, "Impact of pH on the antifungal susceptibility of vaginal Candida albicans", Int. J. Gynaecol. Obstet, 114, pp.278~280 (2011)
- Zhang YQ, "Requirement for ergosterol in V-ATPase function underlies antifungal activity of azole drugs", PLoS Pathog, 6, pp.e1000939~ (2010)
- Sambade M, "The yeast vacuolar proton-translocating ATPase contains a subunit homologous to the Manduca sexta and bovine e subunits that is essential for function", J. Biol. Chem, 279, pp.17361~17365 (2004)
- Proksch E, "pH in nature, humans and skin", J. Dermatol, 45, pp.1044~1052 (2018)
- Elias PM, "Structure and function of the stratum corneum extracellular matrix", J. Invest. Dermatol, 132, pp.2131~2133 (2012)
- Jensen JM, "Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier", J. Clin. Invest, 104, pp.1761~1770 (1999)
- Lund P, "Coping with low pH: molecular strategies in neutralophilic bacteria", FEMS Microbiol. Rev, 38, pp.1091~1125 (2014)
- Costa FG, "Overcoming pH defenses on the skin to establish infections", PLoS Pathog, 18, pp.e1010512~ (2022)
- Sun JL, "Metabolic profiling of Staphylococcus aureus cultivated under aerobic and anaerobic conditions with (1)H NMR-based nontargeted analysis", Can. J. Microbiol, 58, pp.709~718 (2012)
- Mallory JC, "Dap1p, a heme-binding protein that regulates the cytochrome P450 protein Erg11p", Cyp51p in Saccharomyces cerevisiae, 2005, pp.25, 1669~1679